NEW YORK, Sept. 21, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong are investigating Neos Therapeutics, Inc. (NASDAQGM: NEOS) in relation to possible violations of federal securities laws.
Click here to learn about the case: http://docs.wongesq.com/NEOS-Info-Request-Form-1342. There is no cost or obligation to you.
On October 19, 2015, Neos Therapeutics disclosed that the U.S. Food and Drug Administration has identified deficiencies in the Company's new drug application for Cotempla XR-ODT that preclude discussion of labeling and marketing requirements at this time. Shares of Neos Therapeutics were down more than 23% on intraday trading on October 20, 2015. Then on August 11, 2016, Neos announced its financial results for the second quarter of 2016, reporting it had missed its earnings expectations by a significant $0.49 per share. Following this news, shares of Neos fell from a close of $8.57 per share on August 10, 2016 to a close of $7.27 per share on August 11, 2016. To obtain additional information, contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/NEOS-Info-Request-Form-1342.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neos-shareholder-alert-the-law-offices-of-vincent-wong-launch-investigation-of-neos-therapeutics-inc-for-possible-securities-fraud-violations-300332066.html
SOURCE The Law Offices of Vincent Wong